Pharmacokinetics, safety and immunogenicity of single doses of belatacept administered subcutaneously to healthy subjects
Phase of Trial: Phase I
Latest Information Update: 24 Sep 2016
At a glance
- Drugs Belatacept; Belatacept
- Indications Transplant rejection
- Focus Pharmacokinetics
- 29 Sep 2008 Planned number of patients changed from 154 to actual number 47 as reported by ClinicalTrials.gov.
- 10 Sep 2008 Actual start date changed from Jun 2008 to Aug 2008 as reported by Clinicaltrials.gov.
- 10 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.